Comparison of intra vesical BCG and HIVEC with Mitomycin C in Urinary Bladder carcinoma following TURBT
Phase 4
- Conditions
- Health Condition 1: C67- Malignant neoplasm of bladder
- Registration Number
- CTRI/2020/03/024351
- Lead Sponsor
- orthern railway central hospital New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Histologically confirmed NMIBC Transitional cell carcinoma
Eastern Cooperative Oncology Group performance status < 2
Exclusion Criteria
Clinical stage T2, non-urothelial histology Active urinary tract infection,
MMC allergy
Uncontrolled significant medical or psychiatric disease Concomitant other malignancy
Known vesico ureteral reflux.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method